UPC - Universe Pharmaceuticals INC


3.09
-0.360   -11.650%

Share volume: 155,879
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$3.45
-0.36
-0.10%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
8%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 20%
Performance
5 Days
7.29%
1 Month
2,240.91%
3 Months
400.00%
6 Months
1,327.25%
1 Year
71.67%
2 Year
-9.14%
Key data
Stock price
$3.09
P/E Ratio 
0.00
DAY RANGE
$2.78 - $3.36
EPS 
N/A
52 WEEK RANGE
$0.08 - $5.64
52 WEEK CHANGE
$71.67
MARKET CAP 
11.781 M
YIELD 
N/A
SHARES OUTSTANDING 
3.625 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-24-2025
NEXT EARNINGS DATE
04-15-2025
BETA 
0.30
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$168,050
AVERAGE 30 VOLUME 
$681,518
Company detail
CEO: Gang Lai
Region: US
Website: www.dzrzy.com/
Employees: 220
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Universe Pharmaceuticals INC engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, and dietary supplements.

Recent news
loading